You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vemurafenib

Showing 176 - 186 of 186
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)

Completed
  • Atrial Fibrillation
  • São Paulo, Brazil
    Hospital São Paulo/Hospital Universitário da UNIFESP (University
Nov 21, 2016

Melanoma Trial in Los Angeles, Boston, New York (Ipilimumab (BMS-734016), Vemurafenib)

Terminated
Has Results
  • Melanoma
  • Ipilimumab (BMS-734016)
  • Vemurafenib
  • Los Angeles, California
  • +3 more
Dec 10, 2014

Local Metastatic Melanoma Trial in France (DT01)

Completed
  • Local Metastatic Melanoma
  • Bordeaux, France
  • +11 more
Jun 16, 2016

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in Atlanta, Boston, Richmond (cabozantinib-s-malate,

Terminated
  • Recurrent Melanoma
  • +5 more
  • Atlanta, Georgia
  • +2 more
Sep 23, 2014

Malignant Melanoma With Metastasis Trial in Herlev (Vaccine consisting of a peptide derived from the protein IDO)

Completed
  • Malignant Melanoma With Metastasis
  • Vaccine consisting of a peptide derived from the protein IDO
  • Herlev, Denmark
    Department of Oncology, Herlev Hospital
Sep 25, 2014

Malignant Melanoma Trial in Australia, United States (RO5185426)

Completed
Has Results
  • Malignant Melanoma
  • La Jolla, California
  • +12 more
Jul 29, 2015

Malignant Melanoma, Colorectal Carcinoma Trial in Australia, United States (PLX4032)

Completed
Has Results
  • Malignant Melanoma
  • Colorectal Carcinoma
  • Los Angeles, California
  • +6 more
Aug 18, 2017

Multiple Myeloma Trial in Little Rock (Vermurafenib)

Withdrawn
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Aug 26, 2014

Advanced or Inoperable Malignant Melanoma With BRAF Mutation Trial in United States (P1446A-05, Vemurafenib (Zelboraf®))

Suspended
  • Advanced or Inoperable Malignant Melanoma With BRAF Mutation
  • South San Francisco, California
  • +3 more
Sep 3, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,

Terminated
Has Results
  • Recurrent Melanoma
  • +4 more
  • Akt inhibitor MK2206
  • +2 more
  • Atlanta, Georgia
  • +3 more
May 16, 2014

Hormone Refractory Prostate Cancer Trial in Tianjin (Docetaxel & Prednisone, DP & Targeted drugs, cisplatin & Etoposide)

Unknown status
  • Hormone Refractory Prostate Cancer
  • Docetaxel & Prednisone
  • +3 more
  • Tianjin, Tianjin, China
    Department of Interventional Oncology, Tianjin Medical Universit
Aug 4, 2014